QuiVad

Home / Sweden / Calliditas Therapeutics AB

Calliditas Therapeutics AB

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 2.18% on October 29, 2021. The shaded band is the year shown above.

May 26, 2021 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

69 disclosures on record for this share.
DateFund% of capitalEnd of publication
October 13, 2021Citadel Advisors LLC0.00%still open
October 12, 2021Citadel Advisors LLC0.51%still open
October 11, 2021Arrowstreet Capital Limited Partnership0.90%still open
October 11, 2021Worldquant LLC0.63%still open
October 5, 2021Voleon Capital Management LP0.00%still open
October 4, 2021Voleon Capital Management LP0.50%still open
October 1, 2021Voleon Capital Management LP0.00%still open
September 30, 2021Arrowstreet Capital Limited Partnership0.81%still open
September 29, 2021Worldquant LLC0.52%still open
September 10, 2021Voleon Capital Management LP0.57%still open
September 8, 2021Voleon Capital Management LP0.67%still open
September 2, 2021Voleon Capital Management LP0.71%still open
September 1, 2021Voleon Capital Management LP0.64%still open
August 31, 2021Voleon Capital Management LP0.57%still open
August 23, 2021Voleon Capital Management LP0.00%still open
August 19, 2021Voleon Capital Management LP0.51%still open
July 14, 2021Arrowstreet Capital Limited Partnership0.70%still open
June 7, 2021Arrowstreet Capital Limited Partnership0.61%still open
May 26, 2021Arrowstreet Capital Limited Partnership0.50%still open

Other companies sold short in Sweden

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Calliditas Therapeutics AB, source Finansinspektionen, data as at July 4, 2022, https://www.quivad.com/action/calliditas-therapeutics-ab?page=2